Namocatcat, Allan B.
HRN: 28-01-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2025
METRONIDAZOLE 500MG (TAB)
11/12/2025
11/23/2025
PO
500mg
TID
H.pylori
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes